Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$3.38 - $4.22 $29,466 - $36,789
-8,718 Reduced 4.3%
193,986 $708,000
Q3 2022

Oct 31, 2022

SELL
$3.43 - $5.83 $121,411 - $206,364
-35,397 Reduced 14.87%
202,704 $730,000
Q2 2022

Jul 28, 2022

BUY
$4.41 - $5.69 $107,511 - $138,716
24,379 Added 11.41%
238,101 $1.26 Million
Q1 2022

May 04, 2022

BUY
$4.81 - $6.99 $89,567 - $130,160
18,621 Added 9.54%
213,722 $1.17 Million
Q4 2021

Feb 14, 2022

BUY
$5.97 - $7.93 $201,218 - $267,280
33,705 Added 20.88%
195,101 $1.33 Million
Q3 2021

Nov 12, 2021

SELL
$4.79 - $6.68 $193,659 - $270,072
-40,430 Reduced 20.03%
161,396 $983,000
Q2 2021

Aug 11, 2021

BUY
$5.35 - $6.35 $7,275 - $8,636
1,360 Added 0.68%
201,826 $1.19 Million
Q1 2021

May 12, 2021

SELL
$5.68 - $7.87 $28,979 - $40,152
-5,102 Reduced 2.48%
200,466 $1.21 Million
Q4 2020

Feb 11, 2021

SELL
$5.25 - $8.56 $19,482 - $31,766
-3,711 Reduced 1.77%
205,568 $1.42 Million
Q3 2020

Nov 17, 2020

SELL
$5.78 - $7.47 $21,091 - $27,258
-3,649 Reduced 1.71%
209,279 $1.31 Million
Q2 2020

Aug 13, 2020

SELL
$4.5 - $7.02 $129,654 - $202,260
-28,812 Reduced 11.92%
212,928 $1.41 Million
Q1 2020

May 13, 2020

SELL
$2.87 - $5.49 $289,976 - $554,693
-101,037 Reduced 29.48%
241,740 $1.12 Million
Q4 2019

Feb 13, 2020

BUY
$3.84 - $4.86 $504,426 - $638,414
131,361 Added 62.13%
342,777 $1.45 Million
Q3 2019

Nov 14, 2019

SELL
$4.86 - $6.05 $145,800 - $181,500
-30,000 Reduced 12.43%
211,416 $1.09 Million
Q2 2019

Aug 13, 2019

SELL
$4.51 - $6.6 $428,188 - $626,617
-94,942 Reduced 28.23%
241,416 $1.36 Million
Q1 2019

May 14, 2019

SELL
$5.16 - $6.85 $164,567 - $218,467
-31,893 Reduced 8.66%
336,358 $2.1 Million
Q4 2018

Feb 13, 2019

BUY
$4.89 - $7.16 $529,293 - $774,998
108,240 Added 41.63%
368,251 $1.87 Million
Q3 2018

Nov 13, 2018

SELL
$6.89 - $7.78 $413,400 - $466,800
-60,000 Reduced 18.75%
260,011 $1.88 Million
Q2 2018

Aug 14, 2018

SELL
$5.19 - $7.25 $343,531 - $479,884
-66,191 Reduced 17.14%
320,011 $2.14 Million
Q1 2018

May 15, 2018

SELL
$3.56 - $5.74 $32,040 - $51,660
-9,000 Reduced 2.28%
386,202 $2.12 Million
Q4 2017

Feb 13, 2018

BUY
$2.76 - $3.95 $1.09 Million - $1.56 Million
395,202
395,202 $1.34 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $351M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Millrace Asset Group, Inc. Portfolio

Follow Millrace Asset Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millrace Asset Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Millrace Asset Group, Inc. with notifications on news.